{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:23:43Z","timestamp":1793276623751,"version":"4.5.0"},"reference-count":70,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["OMICS: A Journal of Integrative Biology"],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:p>Carbonic anhydrase II (CAII) is one of the zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide, leading to the formation of bicarbonate and proton. CAII plays a significant role in health and disease. For example, CAII helps to maintain eye pressure while regulating the pH of the tumor microenvironment, and by extension, contributing to cancer progression. Owing to its remarkable role in cancer, visual health, and other human diseases, CAII can serve as an attractive therapeutic target. We report an original study based on high-throughput virtual screening of natural compounds from the ZINC database in search of potential inhibitors of CAII. We selected the hits based on the physicochemical, absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, pan-assay interference compound (PAINS) patterns, and interaction analysis. Importantly, two natural compounds were identified, ZINC08918123 and ZINC00952700, bearing considerable affinity and specific interactions to the residues of the CAII-binding pocket with well-organized conformational fitting compatibility. We investigated the conformational dynamics of CAII in complex with the identified compounds through molecular dynamics simulation, which revealed the formation of a stable complex preserved throughout the 100 ns trajectories. The stability of the protein\/ligand complexes is maintained by significant numbers of noncovalent interactions throughout the simulations. In conclusion, natural compounds identified in the present study specifically and computer-assisted drug design broadly offer a reliable resource and strategy to discover potential promising therapeutic inhibitors of CAII to cure various cancers and glaucoma after further experimental validation and clinical studies.<\/jats:p>","DOI":"10.1089\/omi.2021.0059","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T15:32:12Z","timestamp":1626190332000},"page":"513-524","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["Discovery of Natural Compounds as Potential Inhibitors of Human Carbonic Anhydrase II: An Integrated Virtual Screening, Docking, and Molecular Dynamics Simulation Study"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-6015","authenticated-orcid":false,"given":"Farah","family":"Anjum","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Jamia Millia Islamia, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-4835","authenticated-orcid":false,"given":"Taj","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-3611","authenticated-orcid":false,"given":"Alaa","family":"Shafie","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tbilisi State Medical University, Tbilisi, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekhzod","family":"Abdullaev","sequence":"additional","affiliation":[{"name":"Scientific Department, Akfa University, Tashkent, Uzbekistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-4940","authenticated-orcid":false,"given":"Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.proche.2015.12.064"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040884"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389203715666140327114232"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2017.1405263"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.2945165"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28312"},{"key":"e_1_3_5_8_1","first-page":"17","article-title":"Receptor chemoprint derived pharmacophore model for development of CAIX inhibitors","volume":"8","author":"Amresh P","year":"2013","unstructured":"Amresh P, , Kumar K, , Islam A, , Hassan I, , and Ahmad F. (2013). Receptor chemoprint derived pharmacophore model for development of CAIX inhibitors. J Carcinog Mutagen S, 8, 17\u201320.","journal-title":"J Carcinog Mutagen S"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom10040527"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115424"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.12.049"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2010.07.010"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr960370z"},{"key":"e_1_3_5_14_1","first-page":"CA","article-title":"Discovery studio modeling environment","author":"Biovia DS","year":"2017","unstructured":"Biovia DS. (2017). Discovery studio modeling environment. San Diego, CA.","journal-title":"San Diego,"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560071201"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi902178w"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.06.158"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2016.10.073"},{"key":"e_1_3_5_21_1","first-page":"1","article-title":"Design and development of 5-(4H)-oxazolones as potential inhibitors of human carbonic anhydrase VA: Towards therapeutic management of diabetes and obesity","author":"Das Mahapatra A","year":"2020","unstructured":"Das Mahapatra A, , Queen A, , Yousuf M, et al. (2020). Design and development of 5-(4H)-oxazolones as potential inhibitors of human carbonic anhydrase VA: Towards therapeutic management of diabetes and obesity. J Biomol Struct Dyn. 1\u201311.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_5_22_1","first-page":"2315","article-title":"Carbonic anhydrase inhibitors","volume":"15","author":"De Simone G","year":"2005","unstructured":"De Simone G, , Di Fiore A, , Menchise V, et al. (2005). Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: Solution and X-ray crystallographic studies. Bioorg Med Chem Lett, 15, 2315\u20132320.","journal-title":"Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: Solution and X-ray crystallographic studies. Bioorg Med Chem Lett"},{"key":"e_1_3_5_23_1","first-page":"82","article-title":"PyMOL: An open-source molecular graphics tool","volume":"40","author":"DeLano WL","year":"2002","unstructured":"DeLano WL. (2002). PyMOL: An open-source molecular graphics tool. CCP4 Newsl Protein Crystall, 40, 82\u201392.","journal-title":"CCP4 Newsl Protein Crystall"},{"key":"e_1_3_5_24_1","first-page":"States","article-title":"Molecular Recognition: Pharmacological Aspects","author":"Dukhovich F","year":"2004","unstructured":"Dukhovich F. (2004). Molecular Recognition: Pharmacological Aspects. Nova Publishers, United. States.","journal-title":"Nova Publishers, United"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2796"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2019.1664937"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103557"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2019.117453"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109245"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.04.044"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2015.1046934"},{"key":"e_1_3_5_32_1","first-page":"Ltd","article-title":"Hydrogen Bonds in Proteins: Role and Strength","author":"Hubbard RE","year":"2001","unstructured":"Hubbard RE, , and Kamran Haider M. (2001). Hydrogen Bonds in Proteins: Role and Strength. In: eLS. John Wiley & Sons, Ltd.","journal-title":"In: eLS. John Wiley & Sons,"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.04.131"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2016.06.080"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.07.010"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2016.1149097"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci049714"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700752"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2016.01.006"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2009.11.011"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb17614.x"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1993.1365"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/metabo8010019"},{"key":"e_1_3_5_44_1","first-page":"489","article-title":"Binding of small-molecule ligands to proteins: \u201cwhat you see\u201d","volume":"17","author":"Mobley DL","year":"2009","unstructured":"Mobley DL, , and Dill KA. (2009). Binding of small-molecule ligands to proteins: \u201cwhat you see\u201d. is not always \u201cwhat you get.\u201d Structure, 17, 489\u2013498.","journal-title":"is not always \u201cwhat you get.\u201d Structure"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2018.1468282"},{"key":"e_1_3_5_46_1","doi-asserted-by":"crossref","unstructured":"Mohammad T Mathur Y and Hassan MI. (2020a). InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief Bioinformatics. https:\/\/doi.org\/10.1093\/bib\/bbaa279","DOI":"10.1093\/bib\/bbaa279"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198102"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25040823"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.129977"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026618666181025114157"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.10.143"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2016.12.024"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2015-0132"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28774"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.35176"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.77119"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00104"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.08.082"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1200"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.3762\/bjoc.11.127"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444904003166"},{"key":"e_1_3_5_62_1","first-page":"349","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","author":"Scozzafava A","year":"2014","unstructured":"Scozzafava A, , and Supuran CT. (2014). Glaucoma and the applications of carbonic anhydrase inhibitors. In: Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Eds: Frost SC, and McKenna R. Springer Nature, USA, pp. 349\u2013359.","journal-title":"In: Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Eds: Frost SC, and McKenna R. Springer Nature, USA, pp"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000634"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103754"},{"key":"e_1_3_5_65_1","first-page":"81","article-title":"The small molecule drug discovery process\u2014from target selection to candidate selection","author":"Stocks M","year":"2013","unstructured":"Stocks M. (2013). The small molecule drug discovery process\u2014from target selection to candidate selection. In: Introduction to Biological and Small Molecule Drug Research and Development. Eds: Ganellin R, Roberts S, and Jefferis R. Elsevier, pp. 81\u2013126.","journal-title":"In: Introduction to Biological and Small Molecule Drug Research and Development. Eds: Ganellin R, Roberts S, and Jefferis R. Elsevier, pp"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2012.672983"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.10025"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_5_69_1","unstructured":"Turner PJ. (2009). ACE\/gr development team (1998-05-13). Xmgr: Daftar\/Tabel\u2014changes."},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20291"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/prot.340150110"}],"container-title":["OMICS: A Journal of Integrative Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/omi.2021.0059","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/omi.2021.0059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/omi.2021.0059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:04:54Z","timestamp":1777676694000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/omi.2021.0059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"alternative-id":["10.1089\/omi.2021.0059"],"URL":"https:\/\/doi.org\/10.1089\/omi.2021.0059","relation":{},"ISSN":["1536-2310","1557-8100"],"issn-type":[{"value":"1536-2310","type":"print"},{"value":"1557-8100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}